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The  group-specific polysaccharide  (PS) a isolated  from group A  streptococcal cell 
wall consists of a polyrhamnose backbone (alternating a- 1,2 and a- 1,3 linkages) which 
has fi-1, 3-1inked N-acetyl-D-glucosamine (NADG) residues attached to the available 
3  position  in  the  backbone  (1-4).  Fung  et  al.  showed  that  the  PS  molecule  is 
heterogeneous  because  of varying  amounts  of  NADG  attached  to  the  rhamnose 
backbone  (5).  The  antibody  raised  against  PS  is  reported  to  cross-react  with  a 
glycoprotein of connective tissue (6) and with antigens of thymus and skin epithelial 
cells  (7).  In  various  animal  models  of chronic  inflammation  induced  by group  A 
streptococcal cell walls (8-13), the PS played an important role in protecting the toxic 
peptidoglycan (PG) moiety from tissue lysozyme and other degradative enzymes (10, 
14).  Although  the PS has been well characterized chemically and immunologically, 
there  have  not  been  any  well-documented  reports  of a  biological  activity  of this 
polymer. 
In  an  earlier study  (15),  we observed that  a  spectrum of various sizes of PG-PS 
fragments  was  obtained  by  treatment  of  group  A  streptococcal  cell  walls  with 
mutanolysin  or phage-associated lysin.  Some of these  fragments induced  edema in 
rats, and the severity of edema was related to the molecular weight of the PS polymer. 
The  present  study  presents  evidence  that  the  active  moiety  responsible  for  the 
edematous responses is the PS and that this property is dependent  upon the NADG 
epitope.  Data  are also  presented  that  suggest  that  the  edema-producing PS  might 
play an important role in the pathogenesis of experimental celI wall-induced polyar- 
thritis in rats (9,  16,  17). 
Materials and Methods 
Preparation  of  Cell  Watt  and  Cell  Wall  Fragments.  Purified  cell  walls  were  prepared  by 
disruption of group A, type 3, strain D-58 streptococci in a Braun shaker (B. Braun Instruments, 
San Francisco,  CA). Cell wall fragments were generated from the cell walls by sonic treatment 
(17)  or  by treatment  with  mutanolysin  (15). The  fragments obtained  by  treatment  with 
mutanolysin included: high molecular weight (HMW) PG-PS (~ 500,000 mol wt), low molecular 
weight (LMW) PG-PS (~30,000  tool w'0, and PG fragments; the PG-PS fragments obtained 
* Supported by grant AM 25733 from the National Institute of Arthritis, Diabetes, Digestive and 
Kidney Diseases. 
a Abbreviations used in this paper: gbw, grams of body weight; HMW, high molecular weight; HSA, human 
serum albumin; LMW, low molecular  weight; MDP, muramyl dipeptide; NADG,  N-aeetyl-D-glucosamine; 
PBS, phosphate-buffered  saline; PG, peptidoglycan; PS, polysaccharide. 
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by sonic treatment were separated by differential centrifugation and included the 100S60 (~5.3 
X  106 mol wt) and  100P60  (~5.0 X  107 tool wt). In certain experiments, the 100P60 was further 
fractionated by filtration through a column of Bio-Gel A-50m, and the fragments eluted in the 
void volume fractions were collected by centrifugation (100,000 g, 60 rain, 4°C) and referred to 
as a  filtered  100P60  preparation. 
Preparation of Group-specific Polysaccharide.  Group-specific PS was isolated from the cell walls 
of group  A  (type 3, strain D-58)  and  group A-variant  (strain A486)  streptococci according to 
the method  described  by Krause  (18)  with  some modifications.  A  cell wall preparation  was 
suspended  in formamide (5 mg/ml) and extraction was performed at  150°C for 20 min. After 
being cooled overnight at  4°C, the extracted  preparation  was centrifuged  (36,000  g, 30 min, 
4°C), the supernatant  was mixed with 2 vol of acid-alcohol  (95%  ethanol and  5%  1 N  HCL), 
and the mixture was centrifuged (12,000 g, 30 min, 4°C). The PS in the alcoholic supernatant 
was precipitated by adding 5 vol of acid-acetone (99% acetone and  1% HCL) and a few crystals 
of  sodium  acetate  to  the  supernatant.  This  was  held  at  4°C  for  72  h.  The  acid-acetone 
precipitable  carbohydrate  was  dissolved  in  distilled  water,  clarified  by  centrifugation,  and 
treated with the acid-alcohol and acid-acetone once more. The PS obtained  from the second 
acid-acetone treatment was Suspended in distilled water, dialyzed against distilled water for 48 
h  at 4°C, and passed through  Dowex-50 x  8  (200-400  mesh)  cation exchange resin  (Bio-Rad 
Laboratories,  Richmond, CA) before lyophilization. The lyophitized PS was suspended  in an 
appropriate amount of distilled water and was treated again with acid-alcohol and acid-acetone 
before use. 
An aliquot of the group A PS was also treated with an N-acetyl-n-glucosaminidase to remove 
NADG from the rhamnose  backbone.  The enzyme was prepared  from a  soil bacillus  (strain  2 
aSm)  as described by McCarty  (4).  The enzymatic digestion was performed by incubating a 
solution of the PS  (60  mg in 22 ml of a  buffer containing 0.5 M  sodium  citrate and  0.15  M 
NaCI, pH 6.0)  with 8 ml of the partially purified enzyme (in 0.15 M  NaCI). The mix,are was 
incubated  at  25°C  for  72  h  and  then  heated  at  100°C  for 5  min  to stop  the reaction.  The 
enzyme-treated PS was clarified by centrifugation (25,000 g, 20 min, 4°C) and filtered through 
a  column of Sephadex G- 100. The fractions which contained rhamnose were pooled, dialyzed 
against deionized distilled water, and lyophilized. 
Animals.  We used outbred  female Sprague-Dawley rats  (Zivic-Miller Laboratory,  Allison 
Park,  PA)  that weighed  120-160 g at the beginning of the experiments. 
Iodinatwn of  Human Serum Albumin.  Human serum albumin (HSA) (Cutter Laboratories, Inc., 
Berkeley, CA) was iodinated with lzsI (Amersham Corp., Arlington Heights, IL) by solid-state 
lactoperoxidase as described by David and  Reisfeld (19).  The 125I-HSA  had a  specific activity 
of 94 #Ci/mg HSA, and was diluted with phosphate-buffered  saline (PBS) before use. 
Methods of Inducing and Scoring Edematous Response and Arthritis.  Three routes of injection were 
used to induce edema in the rats,  intravenous  (i.v.), intraperitoneal  (i.p.),  and  intra-articular 
(i.a.).  When  edema was  induced  by i.v. or i.p.  injections, the samples  were dissolved in and 
diluted  with sterile PBS (0.04 M  phosphate,  0.15  M  NaCI; pH  7.2)  and 0.4 ml samples were 
injected.  Intra-articular  injections were performed by injecting  10 ~tl of control  (PBS)  or test 
samples  in PBS through  the Achilles tendon  and  above the calcaneous into the region of the 
tibio-talor joint. In all experiments, each rat was injected with the PBS control in the left joint 
and  the test samples in the right joint. The intensity of edema in each limb was estimated on 
a scale 0-4 by gross observations, or by measuring the amount of 125I-HSA  accumulated in the 
limbs. An earlier report (15) showed that there was an excellent correlation between the clinical 
scoring of edema and the amounts of 125I-HSA  accumulation in the limb (r =  0.97, P <  0.001). 
The  time course of edema  after the i.a.  injection was  determined  by  measuring  I25I-HSA 
accumulation  in the limbs at various times after the limbs were injected with the HMW  PG- 
PS. The 125I-HSA  was injected (i.v., 1.45  ×  10 -a/LCi/g body weight [gbw])  1 h  before the rats 
were scored for edema. The experiment was performed by injecting each of 24 rats (6 groups of 
4 rats each) with  10 p.l of PBS into the left joint and  10/.tg of HMW  PG-PS in  10 ~1 PBS into 
the right joint. At 15, 30, and 60 min, and 4, 24, and 48 h  after i.a. injection, one group of rats 
was scored for edema and immediately anesthesized by ether. The heart blood was withdrawn, 
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limbs and in the  blood were  determined with  a  Gamma counter  (1197  series;  Automatic 
Gamma Counting System, Searle Analytic Inc., Des Plaines, IL). 
The 12~I-HSA was also used to quantitate vascular permeability changes in various tissues 
after the rats were injected systemically with the PS. In these experiments, each member of a 
group of five rats was injected i.v. with 12~I-HSA (1.18 ×  10  -3 #Ci/gbw); after 30 rain, the rats 
were  injected i.v.  with either PBS or with  a  PS  preparation  (6 #g/gbw).  30  min after the 
injection of PBS or PS, the rats were anesthetized by ether, the heart blood was collected, and 
various tissues were removed, including heart, lung, spleen, liver, thymus, kidney, skin (flank), 
muscle (trapezius), submandibular lymph node, mesenteric lymph nodes, ascending colon, as 
well as all four limbs. The amount of x25I-HSA in the tissue and in the blood were determined 
with the Gamma counter. 
Arthritis was induced by a single i.p.  injection of 100P60  preparations (in sterile PBS)  at 
12.75 or 10/~g rhamnose per gbw. The rats were scored for arthritis as described (9). 
Isolation of Edema-producing Activity  from Cell Wall Sonicate.  After sonication of cell walls for 70 
rain (Branson Sonifier, model 350; Branson Sonic Power Co., Danbury, CT), the heterogeneous 
collection of fragments was centrifuged at  100,000 g for 60 rain and the resulting supernatant 
fraction was labeled 100S60. The 100S60 fraction (300 rag)  was dissolved in 10 ml of 0.01 M 
Tris/HC1 (pH 7.4) and filtered through a column of Sepharose 6B equilibrated in the buffer. 
Cell wall fragments retained by the column were concentrated and washed with glass-distilled 
water in a stirred cell equipped with an Amicon UM05 membrane (Amicon Corp., Scientific 
Systems Div., Lexington, MA) and lyophilized. The materials in the lyophilized preparation 
(40 mg) were separated by DEAE-Sephacel ion-exchange chromatography into three fractions, 
designated FI, FII, and FIII. The FI referred to the materials that did not bind to the column. 
The FII and FIII were isolated from the rhamnose-containing fractions that  bound to  the 
column and which were eluted with a linear gradient of NaCI (0-0.15 M). They were separated 
by Sephadex G-100 gel filtration based on differences in their sizes. The FII was eluted in the 
void volume, whereas the FIII was retained by the gel. All fractions which contained rhamnose 
were tested for edema-producing activity by i.a. injections. 
Molecular Weight Determinations.  Molecular weight of the PS was estimated by gel filtration 
using Dextran T  fractions of known molecular weight as markers as previously described (15). 
Chemical Analyses.  Muramic acid and glucose were assayed as their alditol acetates by gas- 
liquid chromatography (20). Samples were hydrolyzed under vacuum for 3 h at  100°C with 2 
N sulfuric acid before derivatization. Rhamnose was assayed according to Dische and Shettles 
(21).  Glucosamine was  determined by  a  modified  Elson-Morgan method  as  described  by 
Blumenkrantz and Asboe-Hansen (22). Amino acid analyses were performed after the samples 
were hydrolyzed in 6 N HCl at  110°C in vacuo for 24 h. Hydrolyzed samples were lyophilized 
to dryness, redissolved in 0.2  M  sodium citrate buffer (pH  2.2),  and centrifuged to remove 
ca,  rmalyzed material. The supernatant was applied to a  gradient high pressure liquid chro- 
matograph system adapted to perform post-column derivatization amino acid analysis (23). 
Muramyl Dipeptide.  Muramyl dipeptide (MDP; N-acetyl-muramyl-L-alanyl-n-isoglutamine) 
and the analog (N-acetylmuramyl-D-alanyl-D-isoglutamine)  were obtained from Sigma Chem- 
ical Co., St.  Louis, MO. They were dissolved in sterile PBS,  and the pH was adjusted to 7.4 
with 1 N NaOH before use. 
Results 
Edema Induced by PS and PG-PS Fragments.  The time course of edema developing in 
the limbs of rats injected with PS or PG-PS depended on the route of injection. When 
injected i.v., the kinetics of the edematous response was similar for PS and HMW PG- 
PS.  Edematous swelling appeared  in 5-10 rain in both front and both hind limbs, 
reached maximal intensity  by 30 rain, began to disappear by 1 b, and was undetectable 
by  10 h.  The minimum amount of PS required to give obvious edema was  1.0/~g/ 
gbw  (Table I). The PS isolated from group A-variant (strain A486)  did not induce 
edema even when injected at  10/~g/gbw, and the glucosaminidase-treated group A 1092  EDEMA  INDUCED  BY  GROUP  A  STREPTOCOCCAL  POLYSACCHARIDE 
TABLE  I 
Response of Rats to i.v. Injection of PS 
PS  Dose (/.tg/gbw) 
Number 
positive/  Average score of 
number in-  positive rats at 30 
min postinjection*  jected 
Group A, strain D58  1.00  1/5  1.0 
2.50  5/5  1.80 +  1.30 
5.00  5/5  10.60 + 3.29 
10.00  4/4  14.75 +  1.66 
Group A-variant strain A486  4.86  0/5 
10.00  0/4 
Enzyme-treated  group A, strain  5.00  0/5 
D58  i0.00  1/4  2.0 
PBS control  0.4 ml  0/5 
* A positive response was indicated by the appearance of edema in the front and hind limbs. 
A  scale of 0-4 was used  to estimate the intensity of edema of each limb; therefore, the 
maximum total score per rat was 16 (mean +  1 SD). 
PS  was  much  less  active  in  inducing  edema  than  was  the  untreated  preparation 
(Table I). 
Edematous  responses could also be induced locally in the limbs when  the edema- 
producing  PG-PS  or  PS  preparations  were  injected  i.a.  (Table  II).  Edema  was  not 
accompanied by detectable erythema and microscopic examination of tissue sections 
gave no evidence of erythrocyte or leukocyte infiltration into edematous joints. The 
time course of edematous responses in the limbs of rats (determined by measurements 
of 12SI-HSA accumulation at various times) was similar to those seen after i.v. injection, 
with the exception that the increase in vascular permeability persisted at a  low level 
for  at  least  24  h  (Fig.  I).  The  dose-response curve  of edema  after  i.a.  injection  of 
HMW  PG-PS is shown in Fig. 2. 
Intraperitoneal injection of the group A PS at 15/zg/gbw resulted in the appearance 
of edema at 60 min. The edematous response reached maximal intensity at 2 h, began 
to decline, and usually was not observable at  15 h. 
Analysis of PS Preparations by Gel Filtration.  The PS from group A  streptococcal cell 
wall was retained by Sephadex G-100 and had a  size slightly larger than  that of the 
PS  isolated from  the group A-variant  (Fig.  3  A-B). Treatment  of group  A  PS  with 
glucosaminidase  for  72  h  resulted  in  a  partial  removal  of glucosamine  from  the 
rhamnose backbone. Enzymatic digestion of the PS was indicated by the appearance 
of a  second  peak of glucosamine which  eluted close to  the  bed  volume  (Vt)  of the 
Sephadex G-100 column (Fig. 4). In addition, the enzyme-treated PS had an average 
size slightly smaller than that of the untreated group A  PS. 
Isolation of Edema-producing Activity from  Cell  Wall Sonicate.  Edema-producing  cell 
wall  fragments  in  the  100S60  fraction  of the  cell  wall  sonicate  were  retained  by 
Sepharose 6B  and were very heterogenous  in size.  Some of these fragments  (FI) did 
not bind to the column of DEAE-Sephacel, which was equilibrated with 0.01  M  Tris/ 
HCI  (pH  7.35),  whereas  other  fragments  (FII and  FIII) bound  to  the  column  and 
were  eluted  by  a  linear  0-0.15  M  NaCI  gradient.  The  FII  was  excluded  by  the 
Sephadex G-100 column but  the FIII was retained by the column and had a  K,v of 
0.29, MN =  26,000.  All fractions induced edematous responses (Table II). CHAMROEN  CHETTY,  ROGER  R.  BROWN,  AND JOHN  H.  SCHWAB 
TABLE  II 
Response of Rats to i.a. Injection of Various PG-PS, PS, and PG Fragments 
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Preparation  Dose 
Num~r 
positive/  Average score of 
number in-  positive rats at 30 
min postinjection*  jetted 
Fragments generated by mutanolysin 
HMW PG-PS 
(~500,000  tool wt) 
LMW PG-PS 
(~30,000  tool wt) 
LMW PG:[: 
Group A PS 
Group A-variant PS 
Fragments isolated  from 100S60 
FI 
FII 
FIII 
LMW  fragments derived  from  lOOP60 (re- 
tained by Bio-Gel A-50m) 
MDP 
MDP analog 
Lipopolysaccharide (Salmonella. typhimurium) 
PBS 
ttg/ limb 
2.50 
10.00 
10.00 
20.00 
0.25 
1.25 
5.00 
70.00 
2.50 
10.00 
2.50 
10.00 
2.50 
10.00 
10.00 
5/5  0.88 ± 0.25 
5/5  2.25 ± 0.29 
5/5  1.44 ± 0.52 
0/5 
2/5  0.50 
5/5  1.05 ±  0.67 
5/5  2.20 ±  0.27 
0/5 
4/4  0.63 +  0.14 
4/4  2.75 ±  0.29 
5/5  0.60 ± 0.55 
5/5  1.75 ±  0.29 
5/5  0.70 _  0.45 
5/5  2.50 ±  0.41 
5/5  1.20 ±  0.57 
300.00  0/5 
300.00  0/5 
0.10  0/5 
1.00  0/5 
10.00  0/5 
10 ~1  0/5 
* A positive response was the appearance of edema in the right limb (sample-injected limb). A scale of 
0-4 was used to estimate the intensity of edema of the limb (Mean ±  1 SD). 
:~ Retained by Sephadex G 25 (15). 
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Flo.  1.  Time-course of edema after i.a. injection of HMW PG-PS.  (e) ~2SI-HSA in the HMW PG- 
PS injected limb; (©) PBS-injected limb. Each dot represents the mean of four rats and the bracket 
represents the standard error of the mean. There were no significant differences  in the level of 
]25I-HSA in the blood (cpm/ml) of the 24 rats. 
Chemical Analyses  (Table III).  The  PS preparations used in our studies contained 
no  detectable amounts  of muramic  acid  (<0.3%  wt/wt),  contained  <0.3%  alanine, 
glutamic  acid,  and  lysine and  contained  only  small  amounts  of other amino  acids 1094  EDEMA  INDUCED BY  GROUP  A  STREPTOCOCCAL  POLYSACCHARIDE 
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Fro,  2.  Dose response curve of edema induced by i.a.  injection of the HMW PG-PS. Each group 
of four rats was injected  with HMW PG-PS  (0_1-50  ttg/limb). Each  dot  represents the mean -4- 
SEM. 
A vo  ~av  =0-37, Mn =21,000  V  t 
so-  ~  "  A  1 
so-  ~  ~  SSmNOSE  S0 
! 20-  20 zw  f:oi 
it;  10- 
0 
160  240  320  400  480 
ELUTION VOLUME  (mr) 
B Vo  Kov=0.47,  ]~n =  14,500  V  t 
[60  .~~~ 
A ~120  ~  RHAMNOSE  OSAMINE  ~" 
80  }8o., 
t~o~ 
,o 
i  i.ao 
o  ~  Zo 
16o  240  szo  460  ,~o 
ELUTION VOLUME  (m[) 
FIO.  3.  Sephadex G-t00 elution profiles of polysaccharides isolated from (A) group A strain D58 
and (B) group A-variant strain A486  streptococci. A sample (6 mg of group A polysaccharide or 10 
mg of group A-variant polysaccharide) was dissolved in 1 ml of 0,01 M Tris/HCI (pH 7.4), applied 
to a column of Sephadex G-100 (2.6 x  94 cm), and eluted with Tris/HCl at 4°C at a flow rate of 
18 ml/h. Fractions (4.6 ml) were assayed for rhamnose (0) and glucosamine (©). 
(<0.05% wt/wt). The enzyme-treated PS had significantly lower glucosamine content 
than  did the  untreated  PS.  The composition of the  various edema-producing frag- 
ments in the  100S60  indicated the heterogeneity of these fragments. The FI consisted 
of the  PS  and possibly some membranous contaminants, whereas the  FII and FIII 
consisted primarily of PG-PS fragments. The ratio of the PS to the PG components 
of the FIII was much higher than that of the FII. 
Vascular Permeability Changes after i.v. Injection of Edema-producing PS.  30 min after i.v. 
injection of group A PS (6/.tg/gbw), the amount of 12SI-HSA in the blood decreased 
by 34% when compared with the control group (Table IV). The permeability increase 
of all  four limbs was highly significant  (P <  0.001),  and the increase in the muscle 
and submandibular lymph node was of questionable significance (P <  0.05).  However, CHAMROEN CHETTY,  ROGER  R.  BROWN,  AND JOHN  H.  SCHWAB 
.5ool  A 
//  V ° 
,o  I  \\_  J  \ 
0  -  -  ~  ~  0 
160  240  320  400  480 
ELUTION  VOLUME  (ml) 
FIo. 4.  Sephadex G- 100 gel filtration of the glucosaminidase-group A polysaccharide mixture. The 
incubation mixture (25 ml) was applied to the Sephadex G-100 column (4°C) as described in Fig. 
3. The elution was performed at a flow rate of 27.6 ml/h, and fractions (6.9 ml) were assayed for 
rhamnose (0) and glucosamine (O)- 
1095 
TABLE III 
Composition of PG-PS and PS Fragments 
Component 
~.hamnose 
31ucosamine 
VIuramic acid 
~.lanine 
31utamic  acid 
kysine 
31ucose 
total  non-PG- 
associated 
amino acldz 
* Not detected. 
FI 
Percent  Molar ratio 
wt/wt  to lysine 
Fragments isolated  from  100S60 
5.20  10.12 
3.50  6.25 
ND* 
0.63  2.27 
0.42  0.91 
0.46  1.00 
18.20 
1.53 
Percent 
wt/wt 
FII 
Molar ratio 
to lysine 
11.20  4.59 
6.33  2.38 
1.83  0.49 
4.72  3.56 
2.22  1.01 
2A7  1.00 
380 
1.51 
Percent 
wt/wt 
FllI 
Molar ratio 
to lysine 
20.58  31.93 
t2.50  17.77 
0.39  0.40 
0.87  2.47 
0.84  1.46 
0.57  1.00 
1.82 
3.34 
Group A 
(Percent 
wt/wt) 
55.72 
24.53 
ND 
0.27 
0.12 
0.11 
0.05 
Polysaccharlde 
Enzyme-  Group A-var- 
treated grou F  iant (Percent 
A  (Percent 
wt/wt) 
wt/wt) 
55.00  92.98 
14.50  6.25 
ND  ND 
0.11 
0.1! 
0,05 
0.28 
when the experiment was repeated, the increase in vascular permeability in the muscle 
and submandibular  lymph node was not observed.  On the other hand,  there was a 
slight  decrease in the vascular permeability  in the mesenteric lymph nodes (P <  0.01) 
and ascending colon  (P <  0.05). 
Edema-producing Activity and Arthritogenic Activity of 100P60.  Preliminary experiments 
indicated  that  the  100P60  fraction  of  the  cell  wall  sonicate  (unfiltered  100P60) 
contained  small  amounts  of edema-producing  PG-PS  fragments  (Table  II).  These 
fragments  were retained  by a  Bio-Gel  A-50 m  column and,  thus,  could be separated 
from  the  100P60  (excluded  by  the  gel).  The  100P60,  which  was  free  of  edema- 
producing  activity  (filtered  100P60),  was  significantly  less  arthropathic  than  the 
unfiltered  100P60 when compared on the basis of equal amounts of rhamnose injected 
(Fig.  5). The differences in the severity of arthritis induced by these preparations were 
most easily observed during the first  14 d  (P <  0.01)  and between  day 52 and day 60 
(P <  0.05). The arthropathic activity of the filtered  100P60 was significantly  increased 
when it was mixed with the edema-producing  PS before injection  (Fig.  6). 1096  EDEMA  INDUCED  BY  GROUP  A  STREPTOCOCCAL  POLYSACCHARIDE 
TABLE  IV 
Vascular Permeability Changes after i.v. Injection of Group A  PS and PBS Control 
Tissue 
125I-HSA (cpm/g)* 
PBS  PS 
Blood  15,728 +  1,815~  10,427 _.+ 2,741  P  <  0.01 
Limbs 
Right front  1,134  +  176  6,470 __+ 1,620  P <  0.001 
Left front  1,172  --.+ 296  6,056 +  833  P<  0.001 
Right hind  1,062  +  200  3,120 +  504  P <  0.001 
Left hind  990 +  190  3,580 __+ 155  P<  0.001 
Heart  4,710 +  1,318  3,641 ±  792  NS§ 
Lung  3,976 +  517  3,646 +  941  NS 
Spleen  1,978  +  162  1,949 +  412  NS 
Liver  3,374 +  438  3,248 ±  580  NS 
Thymus  860 +  378  788 ~  151  NS 
Kidney  5,004 +  678  4,506 +  557  NS 
Skin (flank)  971  +  112  1,022  +  175  NS 
Muscle (trapezius)  451  +  82  571  +  162  P <  0.05 
Submandibular lymph node  2,064 +  280  3,981  +  1,637  P <  0.05 
Mesenteric lymph node  2,269 +_  161  1,724  +  313  P<  0.01 
Ascending colon  951  +  136  782  ±  133  P <  0.05 
* Mean +  standard deviation (five rats), 30 rain 
:~ cpm/ml. 
§ Not significant. 
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FIG.  5.  Arthropathic  activity  of an  unfiltered  and  a  filtered  100P60  fraction  of PG-PS.  Each 
100P60 preparation was injected i.p. into a group of t0 rats at 12.75/tg rhamnose/gbw. The average 
score of arthritis from all  10 rats in the group is expressed as mean joint score -+ standard error of 
the mean. The level of significance between the two groups was calculated for each time point by 
Student's t test. (0) unfiltered 100P60;  (O) filtered  100P60. 
Discussion 
The  group-specific PS  isolated  from  group  A  streptococcal cell walls  selectively 
induces  a  rapid  but  transient  edematous  response  in  the  limbs  of  rats  that  is  not 
detected  in other  tissues examined.  The  time-course  of edema  depends  on the route  of 
injection.  To  our  knowledge,  this is the  first  documented  report  of a  biologic  activity 
of the  group  A  PS.  The  PS  preparations  used  in these studies  contained  <  1%  (wt/wt) 
total  amino  acids  and  did  not  contain  muramic  acid  detectable  by  GLC  or  amino 
acid  analyzer.  Therefore,  contamination  with  PG  (if any)  and  other  peptides  was 
minimal.  Other  evidence  to  support  the  idea  that  the  activity  is  associated  with  the 
PS  include  the  findings  that  isolated  PG  fragments  did  not  induce  edema  and  that CHAMROEN  CHETTY,  ROGER  R.  BROWN,  AND JOHN  H.  SCHWAB  1097 
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Fzo.  6.  Enhancement of arthropathic activity of the filtered  100P60 by polysaccharide. A sample 
containing the filtered  100P60  (10/~g rhamnose/gbw) and group A  PS  (15 ~g dry wt/gbw)  was 
injected i.p. into each of 10 rats. The arthritis (0) was scored and expressed as described in Fig. 5. 
Each of the 10 rats in the 100P60 control group (O) was injected with the filtered  100P60 in a dose 
of 10 Fg rhamnose/gbw, and each of the  10 rats in the PS control group (A) received the group A 
PS in a dose of 15/Lg dry weight/gbw. The level of significance was calculated only when both the 
experimental and control groups showed joint inflammation. At time points indicated by asterisks, 
the differences between the experimental and the control group were not significant. 
the edema-producing activity was markedly reduced by glucosaminidase. This effect 
of  glucosaminidase,  combined  with  absence  of  activity  of  group  A  variant  PS, 
indicates that the NADG epitope is a critical structure for this property. 
Morisaki et al. (24)  reported that mutanolysin digests of group A streptococcal cell 
wall  (which was rich in group A  carbohydrate)  could activate murine polyclonal B 
cells.  Because  the  mutanolysin  digests  consist  of PG-PS  complexes  (15,  24),  and 
isolated PG has been described as a  polyclonal B cell activator (25), it is difficult to 
ascribe  the  mitogenic  activity  to  the  PS.  Recently,  it  was  suggested  that  the  PS 
derived from Streptococcus  pyogenes  OK-432 augmented natural killer activity of human 
peripheral blood lymphocytes in vitro (26). The chemical compositions of the PS used 
in their study was not reported; thus, the possibility of PG and other cell wall and/or 
membranous contaminants in the PS preparation cannot be excluded. 
Our  findings  suggest  that  the  edema-producing  PG-PS  and  PS  polymers might 
play a  role in the pathogenesis of cell wall-induced  polyarthritis, although  they are 
not  themselves  arthropathogenic.  The  PS  caused  a  selective  increase  in  vascular 
permeability in  the limbs, and this vascular change might be the initial  event that 
allows localization of the arthropathic cell wall fragments in the synovial tissue. Our 
speculation is based on the finding that the edema-producing PS increased both the 
incidence and the severity of arthritis induced by the 100P60 (Figs. 5, 6). Experiments 
are in progress to examine the effect of the PS on the distribution and degradation of 
arthropathic cell wall fragments in rat tissues. These experiments involve the use of 
solid-phase radioimmunoassays that were recently developed in this laboratory (27). 
The  edematous  response  is  transient  and  limited  to  a  serous  exudate  with  no 
evidence  of erythrocyte  or  leukocyte  movement.  Whether  this  effect  on  vascular 
endothelium of the joints is a direct action of PS or involves activation of inflammatory 
mediators is unknown at this time. The remarkable selectivity for the limbs suggests 
that a specific receptor for the PS may be located in the synovial or the periarticular 
vascular endothelium.  Blood vessels of similar size and structure in different  tissues 1098  EDEMA INDUCED BY GROUP A STREPTOCOCCAL POLYSACCHARIDE 
have been shown to vary also in their response to histamine-type permeability factors 
(28-31). 
Summary 
Edematous responses were induced in the limbs of Sprague-Dawley rats by intra- 
venous, intraperitoneal,  or intra-articular  injections of group-specific polysaccharide 
(PS)  isolated from the cell walls of group A  streptococci. After intravenous injection 
of the edema-producing PS, vascular permeability increase  (measured by 12gI-human 
serum  albumin)  was detected in the limbs, but not in the heart,  lungs, spleen,  liver, 
thymus, kidney, skin, skeletal muscle, submandibular lymph nodes, mesenteric lymph 
nodes, or ascending colon. This indicates a selective effect on vascular endothelium of 
the joints.  Evidence  to suggest  that  the  edema-producing  activity of the  PS  might 
play an important role in the pathogenesis of cell wall-induced polyarthritis included 
the following:  (a)  the presence of edema-producing activity in arthropathogenic cell 
walt preparations;  (b) cell walt preparations  without edema-producing activity were 
significantly less active in inducing arthritis  than were those which contained edema- 
producing activity;  and  (c)  the addition  of edema-producing PS to cell wall  prepa- 
rations increased both the incidence and the severity of arthritis. 
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